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Abstract
Background: The case of adenocarcinoma with human chorionic gonadtropin (HCG), primary in the male gallbladder, 
is extremely rare. A Medline search has shown only a few similar cases reported.
Methods: We herein describe a case of primary gallbladder adenocarcinoma associated by ectopic HCG positive 
tumor cells in a 79-year-old male.
Results: Pathological examination showed a mixture of moderately and poorly differentiated adenocarcinoma with 
ectopic HCG and placental alkaline phosphatase (PlAP) in tumor cells, though the increase of serum or urinary HCG 
secretion was not confirmed. The literatures were also reviewed.
Conclusions: A case of gallbladder cancer with ectopic HCG production is quite rare in the literature, though many 
similar cases in other site, especially in GI tract, are reported. Embryological consideration suggests the increased 
frequency of similar cases more than being thought now.
Background
In gallbladder, human chorionic gonadotropin (HCG)
related carcinoma is exceedingly rare in the literature.
One case of adenocarcinoma with choriocarcinomatous
element though negative by immunostain [1], two adeno-
carcinomas with choriocarcinomatous elements [2,3],
one adenosquamous cell carcinoma [4], nine undifferen-
tiated carcinomas [5] and another one extrauterine tro-
phoblastic tumor (ETT) [6] have been reported. In other
organs, most of the cases with HCG positive, non-gesta-
tional tumors have been reported as non-gestational cho-
riocarcincoma in the gastrointestinal tract such as
stomach [7-10], esophagus [11], colon [12,13] and jeju-
num [14]. Other sites such as brain [15], lung [16,17] and
liver [18] have also been reported. In addition to the
tumor with choriocarcinomatous elements, ectopic pro-
duction of HCG by gastrointestinal tract tumors has also
been reported by many authors either by using radioim-
munoassay [19-22] or by immunohistochemical stain
techniques [23-26].
Here we report a case of adenocarcinoma with ectopic
HCG of the gallbladder. The literatures are also reviewed.
Case report
A 79-y-old Japanese male was admitted to the Samukawa
Hospital (Kanagawa, Japan) because of jaundice in June
2009. Computer tomography (CT) scan and magnetic
resonance imaging (MRI) of the abdominal organs
showed a mass lesion in the gallbladder, and the obstruc-
tive jaundice due to malignancy was suspected. He had
no significant past history. Then he was admitted to the
Tokai University Oiso Hospital (Kanagawa, Japan) for
further examination and surgical treatment. After the
additional examinations, clinical diagnosis of gallbladder
cancer was made and cholecystectomy was performed at
July 7, 2009. No tumorous lesion, suggestive of primary
site, was identified in other organ including testis, medi-
astinum or gastrointestinal tract by CT scan, MRI or
other examination.
For light microscopy, the specimen was fixed in 10%
buffered formalin, and 4 mm-thick tissue slices were
embedded in paraffin. Paraffin sections were stained with
HE. Immunohistochemical detection of various markers
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in tumor was performed by the indirect immunoperoxi-
dase method using antibodies (AE1/AE3; Ventana, HCG;
Dako, βHCG; Dako, human placental lactogen (HPL);
Dako, placental alkaline phosphatase (PlAP); Dako, chro-
mogranin-A (CGA); Dako, CD56; Leika, Insulin; Dako,
Glucagon; Dako, Gastrin; Dako, Prolactin; Dako, alfa-
fetoprotein(AFP); Dako, Japan) [27,28].
Pathological Findings
Pathological examination of the resected gallbladder
revealed a large, ulcerative tumor mass measuring 4.5 cm
× 3.5 × 2.5 cm occupying more than two thirds of the gall-
bladder wall with necrosis (Fig. 1). Microscopic examina-
tions showed two elements, moderately differentiated
tubular adenocarcinoma and rather poorly differentiated
lesion with abortive tubular structures (Fig. 2). The tumor
invaded through the muscle wall but no extension
through the serosa. The TNM stage was T2N0Mo. Resid-
ual gallbladder revealed moderate acute and chronic
inflammatory cell infiltration and mild to moderate fibro-
sis in the wall, though neither the features of cholelithia-
sis nor porcelain gallbladder were evident.
Immunohistochemistry revealed positive staining for
cytokeratin AE1/AE3 in all tumor cells, HCG and βHCG
in the highly atypical tumor cells of poorly differentiated
adenocarcinoma (Fig. 3) and for placental alkaline phos-
phatase (PlAP) in several tumor cells (Fig. 4). Other anti-
gens including HPL, CGA, CD56, insulin, glucagon,
gastrin, prolactin and AFP were negative.
Later than one month after the operation, serum HCG
titer was measured for the first time and was normal, less
than 1 mU/ml. Because of an old male patient with gall-
bladder tumor, preoperative evaluation of HCG was not
performed.
Postoperative chemotheraty with anti-metabolic drug,
Gemcitabine hydrochloride, was done and no apparent
clinical evidence of recurrence has been obtained yet,
more than 11 months after the operation.
Discussion
Although quite rare, some cases of gallbladder carcinoma
with HCG have been described in the literatures (Table
1). The histological diagnoses of these reports were as fol-
low; choriocarcinoma [1-3], adenosquamous cell carci-
noma [4], undifferentiated carcinoma with HCG [5], and
extrauterine epithelioid trophoblastic tumour (ETT)[6].
Many cases of non-gestational choriocarcinoma have
been reported in gastrointestinal tract or other organs [7-
18], though only a few cases were observed in the gall-
bladder. The case reported as non-gestational, extra-uter-
ine choriocarcinoma, primary in the gallbladder, was first
described by Albores-Saavedra and coworkers [1]. The
Figure 1 The resected gallbladder with a large, ulcerative tumor 
mass measuring 4.5 cm × 3.5 × 2.5 cm with severe necrotic 
change.
Figure 2 Tumor composed of two elements, moderately differen-
tiated tubular adenocarcinoma (upper one third) and rather 
poorly differentiated lesion with abortive tubular structures 
(lower two thirds).
Figure 3 Immunohistochemical staining for βHCG in the highly 
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diagnosis of gallbladder adenocarcinoma with choriocar-
cinoma-like areas was only made by histological exami-
nation, though immunostains for the βHCG were
negative and serum or urinary βHCG level was not
described.
Abu-Farsakh and Fraire represented a second case of
coexisting adenocarcinoma and choriocarcinoma of the
gallbladder [2]. This may be the first case of such tumor
documented by positive immunostaining for the βHCG
and the increased levels of serum and urinaryβHCG,
reported in the English language medical literature. Wang
and coworkers reported another case of non-gestational
choriocarcinoma in gallbladder [3]. This case also repre-
sented a mixture of adenocarcinoma and choriocarci-
noma.
Fukuda and Ohnishi reported a case of gallbladder ade-
nosquamous cell carcinoma with immunostain positive
HCG accompanied by the remarkably increased serum
and urinary HCG [4]. The primary lesion in the gallblad-
der was mainly composed of well differentiated adeno-
carcinoma and well differentiated squamous cell
carcinoma, and metastatic tumor was composed of well
to moderately differentiated adenocarcinoma. βHCG
positive tumor cells were observed in the adenocarci-
noma, especially in poorly differentiated areas.
As in these cases of gallbladder carcinoma, most of the
reported cases of non-gestational choriocarcinoma in GI
tract or other sites also revealed a coexistent adenocarci-
noma component [7-17]. The origin of these choriocarci-
nomatous elements is still controversial. The various
theories regarding pathogenesis include its development
from ectopic germ cells or totipotent rests, teratoma,
metaplastic differentiation, or metastasis from the intra-
uterine lesion.
Gastrointestinal tract tumors with ectopic production
of HCG have been reported by many authors [19-26].
Fukayama et al reported the immunoreactive HCG in
51% of 124 cases of gastric carcinoma [23].
In our case, although neither apparent increase of
serum or urinary HCG nor histologically typical chorio-
carcinoma element was confirmed, immunoreactive
βHCG in adenocarcinoma cells was clearly identified
especially in rather poorly differentiated lesion. These
findings are consistent with the category, "adenocarci-
noma with ectopic production of HCG" and the origin of
HCG positive tumor cells in our case might represent a
metaplastic differentiation or dedifferentiation.
Guo and coworkers described 21 cases of undifferenti-
ated carcinoma of the gallbladder and βHCG positive
tumor cells were observed in 9 cases, though serum or
urinary level of βHCG was not described [5]. Cases were
divided into three histological types; small cell type, pleo-
morphic cell type and spindle cell or pseudosarcomatous
type. βHCG positive cancers were identified in four out of
eight cases in pleomorphic cell type and all of five cases in
spindle cell or pseudosarcomatous type tumors. In these
nine cases with βHCG positive tumor cells, six cases were
accompanied by gastrin, somatostatin and/or serotonin
positive tumor cells. Authors suggested the neoplastic
endocrine cells probably arising by divergent differentia-
tion of the primitive neoplastic cells. These tumors may
be categorized in "endocrine cell carcinoma".
Only one case of ETT in the gallbladder with markedly
elevated HCG levels in urine and serum was reported in
the literature [6]. ETT is a rare condition with approxi-
mately 50 reported cases in several organs and originated
from cells of intermediate trophoblast. Immunohis-
tochemical stain reveals positive reactions for epithelial
markers, HCG and placental alkaline phosphatase,
though quite different from our case in histological fea-
tures.
As previously mentioned, the gastrointestinal tract
tumors with ectopic production of HCG have been
reported by many authors [19-26] and gallbladder is
embryologically originates from the hepatic diverticu-
lum, a ventral outgrowth from the intestine. If sensitive
immunohistochemical studies were routinely done in all
of gallbladder tumor, the case with immunoreactive HCG
might be not a quite rare.
Conclusions
A case of gallbladder cancer with ectopic HCG produc-
tion is quite rare in the literature, though many similar
cases in other site, especially in GI tract, are reported.
Embryological consideration suggests the increased fre-
quency of similar cases more than being thought now.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
Figure 4 Immunohistochemical staining for placental alkaline 
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Table 1: Clinicopathological Summary of Patients with Gallbladder Carcinoma and HCG
No Age/sex Cholelithiasis Macroscopic 
type
Microscopic type Immunostains s/u HCG Ref. No
1 63/F + Non-specific AC + Choriocarcinoma HCG (-) ND 1
2 29/F + Protruded AC + Choriocarcinoma HCG (+), AFP (-), CEA (-) Elevated 2
3 48/F - Protruded AC + Choriocarcinoma HCG (+) Elevated 3
4 83/F - Protruded ASC HCG (+), AFP(-), CEA (+) Elevated 4
5 68/F - Infiltrating UC, pleomorphic type HCG (+), VIM (+), CEA (+) ND 5
6 65/F + Protruded UC, pleomorphic type HCG (+), Som (+), CEA (+) ND 5
7 68/F + Protruded UC, pleomorphic type HCG (+), PP (+), Som (+), Gas (+), CEA (+) ND 5
8 68/F - Infiltrating UC, pleomorphic type HCG (+), Gas (+), CEA (+) ND 5
9 69/M - Protruded UC, spindle cell or ps HCG (+), Vim (+), Gas (+), CEA (+) ND 5
10 61/M - Protruded UC, spindle cell or ps HCG (+), Vim (+), Som (+), Gas (+), CEA (+) ND 5
11 66/M - Protruded UC, spindle cell or ps HCG (+), Vim (+), PP (+), CEA (+) ND 5
12 61/F + Protruded UC, spindle cell or ps HCG (+), Vim (+), PP (+), Ser(+), Som (+), 
Gas (+), CEA (+)
ND 5
13 62/F + Infiltrating UC, spindle cell or ps HCG (+), Vim(+), Ser(+), Som(+), Gas (+), 
CEA (+)
ND 5
14 41/F ND ND ETT HCG (+), PlAP (+) Elevated 6
15 79/M - Protruded AC HCG (+), PlAP (+) NM *
s/u:serum and/or urinary; HCG:human chorionic gonadotropin; AC:adenocarcinoma; ND:not described; AFP:alfa-fetoprotein; 
CEA:carcinoembryonic antigen; ASC:adenosquamous cell carcinoma; UC:undifferentiated carcinoma; Vim:vimentin; Som:somatostatin; 
PP:pancreatic polypeptide; Gas:gastrin; ps:pseudosarcomatous; Ser:serotonin; ETT: extrauterine trophoblastic tumor; PlAP:placental alkaline 
phosphatase; NM:not measured; *:our case.
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review by the Editor-in-Chief of this journal.
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